|
 |
Chronic Lymphocytic LeukemiaThis page contains recent news articles, when available, and an overview of Chronic Lymphocytic Leukemia but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Background information on Chronic Lymphocytic Leukemia
Trading Markets (press release),According to the National Cancer Institute, chronic lymphocytic leukemia is the second most common type of leukemia in adults, occurring most often during Treanda Approved For Chronic Lymphocytic Leukemia Treatment - Mar 25, 2008 eMaxHealth.com,FDA has approved Treanda for chronic lymphocytic leukemia treatment. The drug is produced by pharmaceutical company Cephalon. WellPoint to cover Cephalon's newly approved cancer treatment Treanda - Mar 24, 2008 Forbes,The company said its decision on Treanda follows the Federal Drug Administration's approval to grant it orphan drug status for chronic lymphocytic leukemia. Cephalon: FDA OKs Treanda for treatment of chronic lymphocytic ... - Mar 20, 2008 CNNMoney.comTreanda has been granted orphan drug status by the FDA for the treatment of chronic lymphocytic leukemia. The orphan drug designation will provide marketing Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy ... - Mar 20, 2008 WELT ONLINE,..."TREANDA is an important new treatment for patients with chronic lymphocytic leukemia, and this first-cycle approval by FDA represents a significant New Drug Approved for Chronic Lymphocytic Leukemia - Mar 22, 2008 ACS News Center,Patients with chronic lymphocytic leukemia, a relatively slow-growing cancer of the blood and bone marrow, now have a new treatment option. Cephalon’s Treanda to see limited uptake for chronic lymphocytic ... - Mar 14, 2008 Financial Times,...initially see limited uptake in the first-line setting for chronic lymphocytic leukemia (CLL), if approved, physicians interviewed by Pharmawire said. Pregnant Women Exposed to Pesticides May Up Leukemia Risk in Children - Mar 25, 2008 Fashion Monitor Toronto,...chronic myelogenous leukemia (cml) and chronic lymphocytic leukemia. In the United States, approximately 27% of all childhood cancers are leukemias. GNTA: Conference call regarding Approval in Chronic Lymphocytic ... - Mar 18, 2008 Trading Markets (press release),PowerRating | PR Charts ) will host a conference call regarding Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Data. FDA Indicates That Genasense(R) Approval In Chronic Lymphocytic ... - Mar 18, 2008 Medical News Today (press release),...support approval of Genasense(R) (oblimersen sodium) Injection for treatment of patients with relapsed or refractory chronic lymphocytic leukemia (CLL). FDA Indicates That Genasense(R) Approval in Chronic Lymphocytic ... - Mar 17, 2008 PR Newswire (press release),About Chronic Lymphocytic Leukemia CLL is the most common form of leukemia in adults. According to the American Cancer Society, approximately 8000 patients Cephalon’s Leukemia Drug Treanda Gets the FDA Clearance - Mar 21, 2008 eFluxMediaBy Anna Boyd The US Food and Drug Administration has approved Cephalon Inc.’s injectable drug, Treanda to treat chronic lymphocytic leukemia. FDA Approves Treanda To Treat Leukemia - Mar 21, 2008 E Canada Now,Treanda will treat patients with chronic lymphocytic leukemia. Chronic lymphocytic leukemia is a very slowly progressing blood and bone marrow disease. FDA approves new leukemia drug - Mar 20, 2008 United Press InternationalChronic lymphocytic leukemia, or CLL, is a slowly progressing blood and bone marrow disease. The American Cancer Society estimates more than 15000 new cases FDA Approves Cephalon’s Leukemia Drug Treanda - Mar 20, 2008 dBTechno,The drug will treat the blood and bone marrow disease known as chronic lymphocytic leukemia. This is a very slow disease in regards to its progression. FDA Approves New Drug For Treatment Of CLL - Mar 21, 2008 AHNChronic lymphocytic leukemia (also known as "chronic lymphoid leukemia" or "CLL"), is a type of leukemia, or cancer of the white blood cells (lymphocytes). Immunomedics, Inc. (IMMU)'s Milatuzumab receives FDA orphan drug ... - Mar 19, 2008 Checkbiotech.org (press release),Milatuzumab is being studied for the treatment of multiple myeloma, non-Hodgkin's lymphoma, and chronic lymphocytic leukemia. FDA Gives Thumbs Up for Treanda - Mar 25, 2008 FDA news (subscription),Cephalon has received FDA approval for Treanda as a treatment for patients with chronic lymphocytic leukemia. The Treanda (bendamustine hydrochloride) Cephalon's Treanda gets FDA approval - Mar 21, 2008 The Money Times,Chronic lymphocytic leukemia is a slowly progressing disease in which there is an over-production of white blood cells that do not mature into Development announcement expected at ND - Mar 24, 2008 Munster Times,The decision follows the federal government's decision to grant the drug orphan status for the treatment of chronic lymphocytic leukemia. New Drug Added to Arsenal Against CLL - Mar 20, 2008 Cancerpage.com,Chronic lymphocytic leukemia is a slow growing disease characterized by the production of too many white blood cells that do not mature into FDA Okays Bendamustine (Treanda) for CLL - Mar 20, 2008 MedPage Today,Of 301 chronic lymphocytic leukemia patients, 59% of those given bendamustine responded to treatment compared with just 26% of those who received DJ HUGIN NEWS/Micromet Establishes New Scientific -2- - Mar 25, 2008 Ad-Hoc-News (Pressemitteilung),Dr. Keating is a leading expert on chronic lymphocytic leukemia (CLL), and remarked, "The first efficacy data of BiTE antibody MT103/MEDI-538 in the Cephalon wins US approval for leukemia drug - Mar 20, 2008 ReutersWASHINGTON (Reuters) - Cephalon Inc won US approval to sell a chemotherapy drug to treat patients with chronic lymphocytic leukemia (CLL), the company said Genasense Approval Delayed Again - Mar 24, 2008 FDA news (subscription),...for leukemia drug Genesense are not adequate to support approval of the drug, which is designed for relapsed or refractory chronic lymphocytic leukemia. Cephalon CEO gets $16M compensation - Mar 24, 2008 BusinessWeek...its chemotherapy drug for patients with chronic lymphocytic leukemia, a slowly progressing cancer that effects the blood and bone marrow. BIOTECH STOCKS Drug stocks gain on positive economic data - Mar 24, 2008 MarketWatch...the biotech group announced that the Food and Drug Administration had approved its drug Treanda for the treatment of chronic lymphocytic leukemia. , Flow Cytometry and Molecular Genetics for Hematologic Neoplasms - Mar 21, 2008 Medscape (subscription)...[2,15] These markers can be demonstrated in almost all kinds of B-cell neoplasms with a few exceptions, such as chronic lymphocytic leukemia (CLL). Novel anti-CD20 monoclonal antibody ofatumumab demonstrates anti ... - Mar 4, 2008 PR-USA.net (press release),Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia. Immunomedics Develops New Immunoconjugates for Targeted ... - Mar 20, 2008 Primenewswire (press release),...milatuzumab in NHL, chronic lymphocytic leukemia, and multiple myeloma, and 131I-labetuzumab as an adjuvant therapy in metastatic colorectal cancer. Cephalon wins approval to sell leukemia treatment - Mar 20, 2008 Philadelphia Inquirer,...option for about 15000 people in the US diagnosed annually with the slow-progressing form of leukemia, known as chronic lymphocytic leukemia, or CLL. FDA Approves Cephalon Chemotherapy Drug For Leukemia Patients - Mar 20, 2008 Chatter Shmatter,The drug comes in an injectable form and has been approved for patients diagnosed with chronic lymphocytic leukemia. The company hopes to have it available Genta Says FDA Needs Addl. Data To Approve Genasense For Treatment ... - Mar 17, 2008 RTT News,...data are not adequate to support approval of Genasense Injection for treatment of patients with relapsed or refractory chronic lymphocytic leukemia. Kanzius’ waves of change (AUDIO & VIDEO) - Mar 9, 2008 GoErie.com,He was diagnosed with chronic lymphocytic leukemia in 2002 and continues to be treated for the cancer. He invented his radio-frequency generator in 2003 Superhero With a Stenograph - Mar 22, 2008 New York Times,Last year doctors told him that he had chronic lymphocytic leukemia, which he said stemmed from exposure to Agent Orange. The doctors told him he had many Cephalon Gets FDA Nod for Novel CLL Chemotherapy - Mar 22, 2008 Genetic Engineering News (press release),Cephalon received a green light from the FDA for Treanda as a treatment for chronic lymphocytic leukemia (CLL). The company expects to make this injection FDA OKs Cephalon drug - Mar 21, 2008 Trading Markets (press release),...for about 15000 people in the United States diagnosed annually with the slow-progressing form of leukemia known as chronic lymphocytic leukemia, or CLL. Cephalon, investors await FDA Treanda decision - Mar 19, 2008 FierceBiotech,Some expect a sharp upturn if the agency approves Treanda for chronic lymphocytic leukemia. "This is the first big step. It will be the foundation for our Biotech Busine$$ Daily (AMLN, BIIB, CEPH, CYTK, ONXX, REGN, THRX, CBM) - Mar 24, 2008 24/7 Wall St.,Last Thursday, they received FDA approval for Treanda, a treatment for chronic lymphocytic leukemia. The 52-week high is $84.83. Genta says FDA approval of Genasense will require additional ... - Mar 17, 2008 CNNMoney.com...of Genasense injection for the treatment of patients with relapsed or refractory chronic lymphocytic leukemia will require additional confirmatory data. Vietnam vet fighting leukemia and the VA - Mar 17, 2008 Coos Bay World,He has since been diagnosed with chronic lymphocytic leukemia. Fellow veterans and doctors have suggested his illnesses are linked to his contact with Agent Cephalon Could Turn Tide If Cancer Drug Is Approved - Mar 19, 2008 Wall Street JournalThe Food and Drug Administration decision tomorrow on whether or not to approve Treanda for treating chronic lymphocytic leukemia, or CLL, is sure to affect Government-Owned Inventions; Availability for Licensing - Feb 29, 2008 Trading Markets (press release),In vitro data shows activity of Eeyarestatins against primary cells from patients with chronic lymphocytic leukemia. Clinical trials show that Bortezomib is Treanda approved for CLL - Mar 21, 2008 Prescribing Reference,The FDA has approved Cephalon’s Treanda (bendamustine HCl injection) for the treatment of chronic lymphocytic leukemia (CLL). Treanda is believed to induce Treanda Treats Rare Cancer - Mar 20, 2008 U.S. News & World Report,...has been approved by the US Food and Drug Administration to treat chronic lymphocytic leukemia, a rare cancer that affects the blood and bone marrow. FDA Clears Cephalon Chemotherapy Drug - Mar 20, 2008 Houston Chronicle,The Food and Drug Administration approved the chemotherapy drug for patients with chronic lymphocytic leukemia, a slowly progressing cancer that effects the Market Report -- In Play (CEPH) - Mar 20, 2008 MSN Money...hydrochloride) for Injection for the treatment of patients with chronic lymphocytic leukemia, a slowly progressing blood and bone marrow disease. FDA: Genasense Approval Will Require Additional Data - Mar 18, 2008 FDA news (subscription),...decided available data are not adequate to support approval of Genta’s Genasense for patients with relapsed or refractory chronic lymphocytic leukemia. MethylGene Reports Fourth Quarter and Full Year 2007 Financial Results - Mar 7, 2008 FOXBusinessInitiated three additional clinical trials with MGCD0103: a Phase II single-agent trial in chronic lymphocytic leukemia (Trial 009); a Phase I combination Immunomedics gets FDA orphan drug designation for milatuzumab - Mar 18, 2008 CNNMoney.com...to evaluate the 'therapeutic potential' of milatuzumab in patients with multiple myeloma, non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Search the web for more resources on Chronic Lymphocytic Leukemia |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2006 MONGABAY.COM |